In the 1st Supplement of the Official Gazette No. 107 of December 24, 2019, the Reform of the Criminal Law was published, which will enter into force…

Sophia Ononye outlines the history of cannabis as a medicine in the US and, following the first FDA approval of a cannabis-derived drug product in…

PharmaBoardroom’s new InFocus section examines the fast-growing and lucrative global medical cannabis market, touching on investment opportunities,…

Dr Tares Krassanairawiwong, secretary-general of the Thai FDA shares the recent reforms carried out in the hope of facilitating greater patient access…

GW Pharmaceuticals reports that sales of its CBD drug Epidiolex more than doubled in the second quarter of 2019, demonstrating that cannabinoid-based…

Dentons Germany's Peter Homberg outlines the key requirements that companies need to fulfil in order to import medical cannabis into Germany and how…

Thailand has recently gained a new status as the first Asian country to legalise medical cannabis for medical treatment and research. In a sweeping…

Five of the key emerging trends in the booming global medical cannabis and cannabinoid medicine industries. Increasing Acceptance The…

A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial for companies hoping to succeed in…

David Bearman makes the historical case to be once again considered as a medicine across the USA, noting that economic – rather than health –…

Lawyer Ira Perić Ostojić highlights recent regulatory updates in Croatia, where the legal status of cultivating and producing cannabis for medical…

Monica Weldon looks at the history of medicinal CBD, its current usages in the USA, and why robust scientific research on its efficacy need to be…